EUVIMEDEUVIMED entdecken
Crossref

In vitro and in vivo anti-inflammatory and antinociceptive activities of a synthetic hydrangenol derivative: 5-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one

Hyung-Seok Yoo, Young-Seo Yoon, Jeong-Won Shin, Se-In Choi, Seung Hwan Son, Yoon Hu Jang, Yo-Sep Yang, Soo-Yeon Kim, Ye-Rin Kim, Kyung-Sook Chung, Kyung-Tae Lee, Nam-Jung Kim

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Hyung-Seok Yoo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental Pharmaceutical Science, Graduate School, Kyung Hee University, Seoul 02447 Republic of Korea. Hauptthemen laut MEDLINE: Analgesics, Anti-Inflammatory Agents, Macrophages, Benzopyrans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Korea Ministry of Health and Welfare, Korea Health Industry Development Institute, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the present study, we developed and synthesized novel hydrangenol derivatives and featured their anti-inflammatory activities. Especially, a synthetic derivative 11 (compound 11), which possesses the 4H-1-benzopyran-4-one moiety, 5-hydroxyl group in A-ring, and 4'-hydroxyl group in B-ring, most dominantly downregulated nitric oxide (NO) and prostaglandin E2 (PGE2) production in lipopolysaccharide (LPS)-induced RAW264.7 macrophages. In addition, compound 11 suppressed the inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin 6 (IL-6) expression by inhibiting nuclear factor kappa-B (NF-κB), activator protein 1 (AP-1), and signal transducer and activator of transcription protein (STAT) pathways in LPS-provoked RAW264.7 macrophages. Additionally, we confirmed that compound 11 had better plasma stability than hydrangenol with a plasma-labile δ-valerolactone moiety. In carrageenan-induced rats, compound 11 potently reduced paw inflammation (as measured by paw volume, width, and thickness) by inhibiting the iNOS and COX-2 expression in paw tissue, thereby reducing inflammatory pain. All things considered, as compound 11 shows anti-inflammatory and antinociceptive properties, converting metabolically unstable hydrangenol into a stable compound 11 could be a promising strategy for developing new drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesicsAnti-Inflammatory AgentsMacrophagesBenzopyransEdemaAnimalsMiceRAW 264.7 CellsLipopolysaccharidesMaleNitric OxideNitric Oxide Synthase Type IIDinoprostoneCyclooxygenase 2CarrageenanRatsCytokinesRats, Sprague-DawleyNF-kappa BInflammation

Stichwörter der Autor:innen

4H-chromen-4-oneAnti-inflammationCarrageenan-induced paw edemaHydrangenolPlasma-stability

Substanzen

AnalgesicsAnti-Inflammatory AgentsLipopolysaccharidesNitric OxideNitric Oxide Synthase Type IIDinoprostoneCyclooxygenase 2CarrageenanCytokinesNF-kappa B

Autor:innen und Institutionen

  • Department of Fundamental Pharmaceutical Science, Graduate School, Kyung Hee University, Seoul 02447 Republic of Korea.
  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447 Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447 Republic of Korea.
  • College of Pharmacy, Kangwon National University, 1 Kangwondaehak-gil, Chuncheon 24341 Kangwon-do, Republic of Korea.
  • Department of Fundamental Pharmaceutical Science, Graduate School, Kyung Hee University, Seoul 02447 Republic of Korea; Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul…
  • Department of Fundamental Pharmaceutical Science, Graduate School, Kyung Hee University, Seoul 02447 Republic of Korea; Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447 Republic of Korea. E…

Förderung

  • Korea Ministry of Health and Welfare
  • Korea Health Industry Development Institute
  • National Research Foundation of Korea

Zitieren

APA

Yoo, H. S., Yoon, Y. S., Shin, J. W., Choi, S. I., Son, S. H., Jang, Y. H., Yang, Y. S., Kim, S. Y., Kim, Y. R., Chung, K. S., Lee, K. T., & Kim, N. J. (2025). In vitro and in vivo anti-inflammatory and antinociceptive activities of a synthetic hydrangenol derivative: 5-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114175

Vancouver

Yoo HS, Yoon YS, Shin JW, Choi SI, Son SH, Jang YH, et al. In vitro and in vivo anti-inflammatory and antinociceptive activities of a synthetic hydrangenol derivative: 5-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114175

BibTeX
@article{Yoo2025,
  author = {Yoo, Hyung-Seok and Yoon, Young-Seo and Shin, Jeong-Won and Choi, Se-In and Son, Seung Hwan and Jang, Yoon Hu and Yang, Yo-Sep and Kim, Soo-Yeon and Kim, Ye-Rin and Chung, Kyung-Sook and Lee, Kyung-Tae and Kim, Nam-Jung},
  title = {In vitro and in vivo anti-inflammatory and antinociceptive activities of a synthetic hydrangenol derivative: 5-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114175}
}
Kostenlos starten →